Kanamycin → Acetosyringone

HRID 2215888

반응식

HRID 2215888 반응식
CC1(C)S[C@@H]2[C@H:7](NC(C(C(O)=O)C3C=CC=CC=3)=O)[C:8](=[O:9])N2[C@H]1C(O)=O.[CH2:27]1[C@H:32](N)[C@@H:31]([O:34][C@H:35]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H:30]([OH:46])[C@@H:29]([O:47][C@H:48]2O[C@H](CO)[C@@H](O)[C@H](N)[C@H]2O)[C@@H:28]1N>>[CH3:7][C:8]([C:27]1[CH:28]=[C:29]([O:47][CH3:48])[C:30]([OH:46])=[C:31]([O:34][CH3:35])[CH:32]=1)=[O:9]

참가 물질

3

반응물 2

HCID 6032KanamycinHCID 20824Carbenicillin

생성물 1

HCID 17198Acetosyringone

실험 절차

After four weeks, the segments were transferred to BS-48 regeneration medium containing 200 mg/L carbenicillin and 25 mg/L kanamycin.

후처리

  1. waitAfter four weeks

출처 및 근거

ORD 기록
ord-61ef8f993e1e4c1bb46c37432f1225a5
출처 데이터셋
uspto-grants-2006_09
특허 번호
US07109392B1

연결된 노트

불러오는 중…